Tradestie Institutional Equity Comparison Engine
MESO vs VCEL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VCEL Overall Edge
VCEL Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vericel Corporation (VCEL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus VCEL at 60.5x Forward P/E and 8.3% operating margin (+26.5% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against VCEL sits in SURGE (13th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
VCEL
MESO N/M vs VCEL 60.5x Fwd P/E
Growth & Margin Winner
VCEL
Op Margin -42.6% vs 8.3% ยท YoY +390.7% vs +26.5%
Momentum & Technical Winner
VCEL
1Y -16.4% vs +43.8% ยท 52W Pos 6% vs 92%
Options & Structure Winner
VCEL
UNCLASSIFIED (37th %ile IV) vs SURGE (13th %ile IV)
MESO
NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap
$1.7B
1M Return
-6.1%
1Y Return
-16.42%
Forward P/E
N/M
Unified AI Score
34.6 / 100
SELL
Tech 25.0
Fund 40.0
Flow 50.0
Mom 50.0
VCEL
NASDAQ
Vericel Corporation
Biological Products, (No Disgnostic Substances)
$57.27
+0.54% 1D
Market Cap
$2.9B
1M Return
+42.71%
1Y Return
+43.75%
Forward P/E
60.5x
Unified AI Score
35.6 / 100
SELL
Tech 50.0
Fund 32.0
Flow 70.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MESO -16.42%
VCEL +43.75%
Spread: +60.17 pp (VCEL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MESO TTM Op. Margin: -42.6%
VCEL TTM Op. Margin: 8.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs VCEL. Trailing 12-month operating profitability (MESO -42.6% vs VCEL 8.3%) and valuation multiples (MESO N/M vs VCEL 60.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MESO | VCEL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7B | $2.9B | Larger Scale | VCEL |
| Trailing P/E Ratio Valuation | N/M | 90.3x | Lower Multiple | VCEL |
| Forward P/E Ratio Valuation | N/M | 60.5x | Lower Multiple | VCEL |
| Revenue Growth (YoY) Growth | +390.7% | +26.5% | Higher Growth | MESO |
| Operating Margin (TTM) Profitability | -42.6% | 8.3% | Higher Margin | VCEL |
| Net Profit Margin Profitability | -47.8% | 10.3% | Higher Margin | VCEL |
| Return on Equity (ROE) Capital Efficiency | -9.9% | 9.4% | Higher ROE | VCEL |
| 52-Week Range Position Momentum | 6% ($12โ$22) | 92% ($29โ$60) | Stronger Trend | VCEL |
| Beta / 30D Volatility Risk Regime | 1.18ฮฒ ยท 78% Vol | 0.30ฮฒ ยท 74% Vol | Lower Realized Risk | VCEL |
| Unified Institutional Score Composite Signal | 34.6 / 100 (SELL) | 35.6 / 100 (SELL) | Higher Composite | VCEL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MESO vs VCEL Buy Guide
MESO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
VCEL
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MESO nor VCEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.